IBL News

According to the Japanese demographics report released by Japanese Ministry of Health, Labour and Welfare (MHLW) in 2014, the number of cancer patients has been on the rise since 1981. In 2014, cancer was listed as the number one cause of death.

We have been continuously involved in the research and development, manufacturing, and supply of antibodies to fight cancers since we first started research and development on Carcinoembryonic antigen (CEA) when our company was established.

We have various antibodies and assay kits that can detect proteins that have been reported to be potentially related to various cancers, such as large intestine cancer, stomach cancer, thyroid cancer, blest cancer, lung cancer, liver cancer, prostate cancer, leukemia, and mesothelial tumors. We hope our antibodies and assay kits contribute to your research.

Cancer and Malignant Tumor related Assay Kits
Cancer and Malignant Tumor related Antibodies


If you have any questions, please feel free to contact us.
Click Here to Contact Us

Sales Support
Diagnostic & Research Reagents Division
TEL: +81 (274) 50 8666
Email: do-ibl@ibl-japan.co.jp